CRISPR

CRISPR2-cryabb

ID
ZDB-CRISPR-180521-6
Name
CRISPR2-cryabb
Previous Names
  • T02 (1)
Target
Sequence
5' - CTCCCCAAATTGCCGGCG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genome Build: GRCz11Chromosome: 5
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
vu613 cryabb
Expression
Gene expression in Wild Types + CRISPR2-cryabb
No data available
Phenotype
Phenotype resulting from CRISPR2-cryabb
No data available
Phenotype of all Fish created by or utilizing CRISPR2-cryabb
Phenotype Fish Conditions Figures
pericardium edematous, abnormal cryabbvu613/vu613 (AB) chemical treatment by environment: cortisol Fig. 5 from Mishra et al., 2018
heart contraction process quality, abnormal cryabbvu613/vu613 (AB) chemical treatment by environment: dexamethasone Fig. 5 from Mishra et al., 2018
heart contraction decreased rate, abnormal cryabbvu613/vu613 (AB) chemical treatment by environment: dexamethasone Fig. 5 from Mishra et al., 2018
lens morphology, exacerbated cryabbvu613/vu613 (AB) stress Fig. 4 from Mishra et al., 2018
heart contraction decreased rate, abnormal cryabbvu613/vu613 (AB) control Fig. 5 from Mishra et al., 2018
pericardium edematous, abnormal cryabbvu613/vu613 (AB) stress Fig. 4 from Mishra et al., 2018
cardiac ventricle dilated, abnormal cryabbvu613/vu613 (AB) chemical treatment by environment: dexamethasone Fig. 5 from Mishra et al., 2018
lens morphology, abnormal cryabbvu613/vu613 (AB) control Fig. 3Fig. 4Fig. 6 from Mishra et al., 2018
pericardium edematous, abnormal cryabbvu613/vu613 (AB) chemical treatment by environment: dexamethasone Fig. 5 from Mishra et al., 2018
atrium dilated, abnormal cryabbvu613/vu613 (AB) chemical treatment by environment: dexamethasone Fig. 5 from Mishra et al., 2018
pericardium edematous, abnormal cryabavu612/vu612; cryabbvu613/vu613 (AB) chemical treatment by environment: cortisol Fig. 5 from Mishra et al., 2018
pericardium edematous, abnormal cryabavu612/vu612; cryabbvu613/vu613 (AB) chemical treatment by environment: dexamethasone Fig. 5 from Mishra et al., 2018
lens morphology, abnormal cryabavu612/vu612; cryabbvu613/vu613 (AB) control Fig. 3 from Mishra et al., 2018
lens morphology, ameliorated cryabbvu613/vu613; vu614Tg control Fig. 6 from Mishra et al., 2018
lens morphology, exacerbated cryabavu612/vu612; cryabbvu613/vu613; vu617Tg control Fig. 5 from Wu et al., 2018
Citations